FDAsafety guidance54% confidence
FDA AP — MYCOPHENOLATE MOFETIL HYDROCHLORIDE (SUPPL)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Mylan Labs Ltd..
Regulatory Analysis
Application ANDA203575. Sponsor: PH HEALTH. Submission status: AP. Submission type: SUPPL. Active ingredients: MYCOPHENOLATE MOFETIL HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Immunology · Immunosuppressant
- Sub-indication
- General
Related signal: Mylan Labs receives AP status for Mycophenolate Mofetil Hydrochloride ANDA203859